Horny goat weed is an herbal supplement made from plants in the Epimedium genus, a group of roughly 62 species native mostly to China. It has been used in traditional Chinese medicine for centuries, primarily for sexual health, joint pain, and fatigue. Today it’s one of the most popular over-the-counter supplements marketed for erectile function and libido, though it also shows promise for bone health. The plant’s key active compound works through a mechanism similar to prescription erectile dysfunction drugs, but the evidence behind it is far thinner.
The Plant and Its Active Compound
Epimedium species are flowering plants in the barberry family. Of the 62 recognized species, 52 grow in China, and five are officially listed in the Chinese Pharmacopoeia for medicinal use. The dried leaves are the part used in supplements, typically sold as capsules, tablets, powders, or liquid extracts.
The compound that gets the most scientific attention is icariin, a flavonoid found throughout the plant. Icariin is responsible for most of the biological effects researchers have studied, including antioxidant, anti-inflammatory, and blood-flow-enhancing activity. When you see a supplement label that says “standardized to X% icariin,” that percentage tells you how concentrated the active ingredient is relative to the total extract.
How It Works in the Body
Icariin’s best-understood mechanism involves the same enzyme targeted by prescription ED medications. It inhibits an enzyme called PDE5, which normally breaks down a molecule that keeps blood vessels relaxed and dilated. By slowing that breakdown, icariin helps blood vessels stay open longer, improving blood flow. This is the same basic pathway that drugs like sildenafil use, though icariin is considerably weaker at it.
Beyond that enzyme-blocking effect, icariin also appears to boost production of nitric oxide, the signaling molecule that triggers blood vessel relaxation in the first place. In rat studies, icariin treatment increased nitric oxide-producing enzyme levels in penile tissue and improved the blood-flow response during nerve stimulation. Researchers have also found that it may have nerve-protective effects, supporting the health of the nerve cells involved in erectile function. This dual action, both improving the chemical signaling and protecting the nerve pathways, is what makes the compound interesting to researchers even though it’s a weaker PDE5 inhibitor than pharmaceutical options.
Evidence for Sexual Health
The sexual health claims are the main reason people buy horny goat weed, but the human evidence is limited. A handful of small clinical trials have tested Epimedium-based products in men with mild to moderate erectile dysfunction. In one randomized, double-blind, placebo-controlled crossover study of 63 men, a tablet containing Epimedium extract taken one hour before sexual activity showed improvements in mild to moderate ED compared to placebo. Side effects in that trial included dizziness (about 13% of participants), facial numbness (1.6%), and rapid heartbeat (1.6%).
Another randomized trial of 94 men (average age 63) found that a capsule containing 5 mg of Epimedium extract taken twice daily improved symptoms of aging that included erectile dysfunction. A broader review found that herbal formulas containing Epimedium showed a higher trend of improvement on standardized erectile function scores compared to placebo, with statistically significant differences specifically in the erectile function domain. These results are encouraging but come from small studies, often using multi-ingredient products, making it hard to isolate exactly how much horny goat weed contributes on its own.
Bone Health and Phytoestrogen Effects
One of the more robust areas of research involves bone density. Icariin acts as a phytoestrogen, a plant compound that can mimic some effects of estrogen in the body. This has drawn particular interest for postmenopausal women, who lose bone density as estrogen levels decline.
A 24-month randomized, double-blind, placebo-controlled trial tested Epimedium-derived phytoestrogen flavonoids in 100 late postmenopausal women whose bone density scores indicated early osteoporosis. The treatment group received a daily dose of 60 mg icariin along with small amounts of two other plant compounds. The results showed that the supplement prevented bone loss compared to placebo, and notably, it did so without causing endometrial thickening or changes in blood estrogen levels. That last point matters because it suggests the bone benefits can occur without the increased uterine cancer risk associated with conventional estrogen therapy.
In animal research, icariin works on bone through a dual mechanism: it stimulates the cells that build new bone while simultaneously suppressing the cells that break bone down. Studies across multiple animal models of osteoporosis, including postmenopausal, steroid-induced, and age-related models, consistently show improved bone structure and mineral density with icariin treatment. When combined with exercise in one study, icariin enhanced bone strength more than either intervention alone.
Dosage and What’s in Supplements
There is no standardized dose for horny goat weed, which is one of the bigger practical problems with using it. The lowest dose shown to be active in a human trial is 60 mg of icariin per day, used in the bone health study over 24 months. Supplement products vary enormously. Some list total extract weight without specifying icariin content, others standardize to a specific percentage of icariin (commonly 10% to 40%), and some don’t disclose meaningful details at all.
Rat studies suggest that higher doses may be needed for testosterone-related effects. Converted to human-equivalent doses, those animal studies used roughly 900 to 1,500 mg of icariin daily depending on body weight, far higher than what most commercial supplements contain. This gap between what’s tested in animals and what’s available in stores is worth keeping in mind when evaluating product claims.
Side Effects and Safety Concerns
Horny goat weed is generally well tolerated at the doses used in clinical research. The most common side effects are mild: abdominal discomfort, nausea, and occasional skin rash. Rare allergic reactions including contact dermatitis have been reported. In clinical trials, no significant liver enzyme elevations or episodes of liver injury have been attributed to the supplement, and a comprehensive toxicology review rated it as an “unlikely cause of clinically apparent liver injury.”
The more serious safety concerns involve drug interactions and contamination. Epimedium may have properties that interfere with enzymes involved in breaking down certain brain chemicals, which could interact dangerously with antidepressants and blood pressure medications. One case report documented a hypertensive emergency with brain hemorrhage in a patient taking a sexual enhancement supplement containing both Epimedium and ginseng, likely related to this enzyme-inhibiting effect combined with the patient’s existing medications. Because supplements in this category are also prone to being spiked with undeclared pharmaceutical ingredients, purchasing from reputable brands that undergo third-party testing is particularly important.
Acute vs. Long-Term Use
Whether horny goat weed works quickly or requires weeks of use likely depends on what you’re taking it for. The PDE5-inhibiting effect on blood flow appears to be at least partially acute, meaning some effect on erectile function could occur within hours of a dose, similar in concept (though not in strength) to how prescription ED medications work. One clinical trial had participants take a tablet one hour before sexual activity, suggesting researchers expected a relatively quick onset.
The bone-protective and nerve-supporting effects, by contrast, are clearly long-term processes. The bone density trial ran for 24 months, and the nerve-protective changes seen in animal studies involved structural remodeling of tissue over weeks. If you’re considering horny goat weed for anything beyond acute sexual function, the available evidence points toward consistent daily use over months before meaningful changes would develop.